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S.3.2.1 Sample preparation
Samples were provided by the collaborator and stored frozen at -20 °C. Samples were prepared in DMSO and water to a final testing concentration of 32 μg/mL or 20 μM (unless otherwise indicated in the data sheet), in 384-well, non-binding surface plate (NBS) for each bacterial/fungal strain, and in duplicate (n=2), and keeping the final DMSO concentration to a maximum of 1% DMSO. All the sample-preparation was done using liquid handling robots. Compounds that showed solubility issues during stock solution preparation are detailed in the data sheet.
S.3.3 Antimicrobial Assay
S.3.3.1 Procedure
All bacteria were cultured in Cation-adjusted Mueller Hinton Broth (CAMHB) at 37 °C overnight. A sample of each culture was then diluted 40-fold in fresh broth and incubated at 37 °C for 1.5-3 h. The resultant mid-log phase cultures were diluted (CFU/mL measured by OD600), then added to each well of the compound containing plates, giving a cell density of 5x10 5 CFU/mL and a total volume of 50 μL. All the plates were covered and incubated at 37 °C for 18 h without shaking.
S.3.3.2 Analysis
Inhibition of bacterial growth was determined measuring absorbance at 600 nm (OD600), using a Tecan M1000 Pro monochromator plate reader. The percentage of growth inhibition was calculated for each well, using the negative control (media only) and positive control (bacteria without inhibitors) on the same plate as references. The significance of the inhibition values was determined by modified Z-scores, calculated using the median and MAD of the samples (no controls) on the same plate. Samples with inhibition value above 80% and Z-Score above 2.5 for either replicate (n=2 on different plates) were classed as actives. Samples with inhibition values between 50 -80% and ZScore above 2.5 for either replicate (n=2 on different plates) were classed as partial actives. Samples with inhibition values between 50 -80% and Z-Score above 2.5 for either replicate (n=2 on different plates) were classed as partial actives.
S.3.4. Antifungal Assay
S.3.4.1 Procedure
Fungi strains were cultured for 3 days on Yeast Extract-Peptone Dextrose (YPD) agar at 30 °C. A yeast suspension of 1 x 10 6 to 5 x 10 6 CFU/mL (as determined by OD530) was prepared from five colonies. The suspension was subsequently diluted and added to each well of the compoundcontaining plates giving a final cell density of fungi suspension of 2.5x10 3 CFU/mL and a total volume of 50 μL. All plates were covered and incubated at 35 °C for 24 h without shaking.
Analysis
Growth inhibition of C. albicans was determined measuring absorbance at 530 nm (OD530), while the growth inhibition of C. neoformans was determined measuring the difference in absorbance between 600 and 570 nm (OD600-570), after the addition of resazurin (0.001% final concentration) and incubation at 35 °C for additional 2 h. The absorbance was measured using a Biotek Synergy HTX plate reader. The percentage of growth inhibition was calculated for each well, using the negative control (media only) and positive control (fungi without inhibitors) on the same plate. The significance of the inhibition values was determined by modified Z-scores, calculated using the median and MAD of the samples (no controls) on the same plate. Samples with inhibition value above 80% and Z-Score above 2.5 for either replicate (n=2 on different plates) were classed as actives. Samples with inhibition values between 50 -80% and Z-Score above 2.5 for either replicate (n=2 on different plates) were classed as partial actives.
S.3.5 Antibiotic standards preparation and Quality control
Colistin and Vancomycin were used as positive bacterial inhibitor standards for Gramnegative and Gram-positive bacteria, respectively. Fluconazole was used as a positive fungal inhibitor standard for C. albicans and C. neoformans. The antibiotics were provided in 4 concentrations, with 2 above and 2 below its MIC value, and plated into the first 8 wells of column 23 of the 384-well NBS plates.
The quality control (QC) of the assays was determined by the antimicrobial controls and the Z'-factor (using positive and negative controls). Each plate was deemed to fulfil the quality criteria (pass QC), if the Z'-factor was above 0.4, and the antimicrobial standards showed full range of activity, with full growth inhibition at their highest concentration, and no growth inhibition at their lowest concentration. 
S .3.5.1. Assay materials
Material
.1 Antibacterial data collection
Inhibition of bacterial growth was determined measuring absorbance at 600 nm (OD600), using a Tecan M1000 Pro monochromator plate reader. The percentage of growth inhibition was calculated for each well, using the negative control (media only) and positive control (bacteria without inhibitors) on the same plate as references.
S.3.6.2 Antifungal data collection
Growth inhibition of C. albicans was determined measuring absorbance at 530 nm (OD530), while the growth inhibition of C. neoformans was determined measuring the difference in absorbance between 600 and 570 nm (OD600-570), after the addition of resazurin (0.001% final concentration) and incubation at 35°C for additional 2 h. The absorbance was measured using a Biotek Synergy HTX plate reader. The percentage of growth inhibition was calculated for each well, using the negative control (media only) and positive control (bacteria without inhibitors) on the same plate as references. Table S1 depicts the antimicrobial activity with % inhibition values.
S.3.6.3 Inhibition
Percentage growth inhibition of an individual sample is calculated based on Negative controls (media only) and Positive Controls (bacterial/fungal media without inhibitors). Please note negative inhibition values indicate that the growth rate (or OD600) is higher compared to the Negative Control (Bacteria/fungi only, set to 0% inhibition). The growth rates for all bacteria and fungi has a variation of -/+ 10%, which is within the reported normal distribution of bacterial/fungal growth. Any significant variation (or outliers/hits) is identified by the modified Z-Score, and actives are selected by a combination of inhibition value and Z-Score.
S.3.6.4. Z-Score
Z-Score analysis is done to investigate outliers or hits among the samples. The Z-Score is calculated based on the sample population using a modified Z-Score method which accounts for 
S.3.6.8. Act
Act: Indicates the number of organism-classes (GN,GP and FG) the compound has been found active against, 0 = no activity.
S.3.6.3.9. Sel
Sel: Indicates compounds that have been selected for further dose response studies, Hit-Confirmation. The selection includes all active as well as compounds with ambiguous results requiring confirmation of activity or inactivity. 
CO-ADD
S.4. Antioxidant Activity
Oxidation is a chemical reaction that can produce reactive oxygen species (ROS) such as H2O2, HOCl, HOBr, ROOH, HNO2, ozone O3, singlet oxygen O2, free radicals like oxygen radical, O2·, superoxide radical anion, O2·¯, hydroxyl radical, ·OH, perhydroxyl radical, ·OOH, alkoxy radical, RO·, peroxy radical, ROO·, and reactive nitrogen species (NOS) nitric oxide, NO·, Nitrogen dioxide, NO2· and peroxynitrite radical, ONOO· leading to chain reactions that may damage cellular components such as proteins (enzyme inhibition, denaturation, degradation), lipids (lipid peroxidation) and DNA (mutations, cancer). An antioxidant is a molecule that prevents the oxidation of other molecules. Antioxidants terminate these chain reactions. Antioxidants are used for two different groups of substances: industrial chemicals added to products to prevent oxidation and natural chemicals found in food and body tissues which exert beneficial health benefits as well as redox signaling. It's a paradox in metabolism that oxygen is required for the existence of life on the Earth and it damages the living cells. Failure of the body to balance or counteract or detoxify the harmful effects of free radicals by means of antioxidants leads to the oxidative stress. Oxidative stress leads to many pathophysiological conditions which include neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, neurodegeneration in motor neuron diseases, the pathologies caused by diabetes, rheumatoid arthritis, gene mutations and cancers, chronic fatigue syndrome, fragile X syndrome, heart and blood vessel disorders, atherosclerosis, heart failure, heart attack and inflammatory diseases. Several antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glutathione S-transferase etc. protect DNA from oxidative stress. Dietary antioxidants, β-carotene, vitamin A, vitamin C, and vitamin E, glutathione (mother of antioxidants), flavonoids, catechins, polyphenols, selenium, etc, are found to exert a beneficial health effect if treated with. Antioxidant potential of the chemicals was estimated using modified DPPH free radical scavenging assay in 96 micro-well flat plates. Stock solutions of the chemicals were prepared as 1 mg/mL in DMSO. Each well was filled in with 200 µL chemical in DMSO starting from 100 µg/mL down to the lowest 20 µg/mL. Then, 5 µL of the DPPH solution (2.5 mg/mL in methanol) was added to each well. After keeping the plate in the darkness for 30 minutes, the optical density of each well was read using Tecan Infinite M 200 micro plate reader at wavelength 517 nm. Percentage of inhibition was calculated using the following formula:
The radical scavenging effect was examined and compared with other natural antioxidant, ascorbic acid which was used as positive control. Figure S1 depicts the relative antioxidant activity of the title compounds with respect to Vitamin C.
